Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer

With docetaxel as effective chemotherapy for hormone refractory prostate cancer (HRPC), the number of new treatment combinations for HRPC is expanding demanding a fast-track screening system. This review elaborates on the use of xenograft models to select the most promising combination therapies for...

Descripción completa

Detalles Bibliográficos
Autores principales: van Weerden, W M, Bangma, C, de Wit, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634688/
https://www.ncbi.nlm.nih.gov/pubmed/19088719
http://dx.doi.org/10.1038/sj.bjc.6604822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634688/
https://www.ncbi.nlm.nih.gov/pubmed/19088719
http://dx.doi.org/10.1038/sj.bjc.6604822

Ejemplares similares